Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim in ITP Patients Resistant to Oral TPO-RAs
NCT07612319Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Mar 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of romiplostim in immune thrombocytopenia (ITP), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Durable Platelet Response Rate at 24 weeks. Started Mar 2026; status: recruiting.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07612319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07612319.